AstraZeneca: Pneumonia trials
The registry lists 12 Pneumonia studies with AstraZeneca as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 1 2Phase 2 2Phase 3 1Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.TerminatedNCT04381494Phase 4Results posted
- Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe PneumoniaTerminatedNCT04369469Phase 3Results posted
- Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated SubjectsCompletedNCT02696902Phase 2Results posted
- Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy AdultsCompletedNCT02255760Phase 1Results posted
- Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILDTerminatedNCT06192004
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese SubjectsTerminatedNCT05794672Phase 1
- COVID-19 Soliris Expanded Access ProtocolNo longer availableNCT04802083
- An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19Status unknownNCT04527133Not applicable
- SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19No longer availableNCT04355494
- Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor AntagonistsCompletedNCT01338363
- An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in InfantsCompletedNCT00369759
- Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung CancerCompletedNCT00081315Phase 2